Quarterly report pursuant to Section 13 or 15(d)

REPORTABLE SEGMENTS (Tables)

v2.4.0.6
REPORTABLE SEGMENTS (Tables)
 9 Months Ended
Jun. 30, 2012
Segment Reporting [Abstract]  
Schedule Of Segment Reporting Information, Profit Or Loss, By Segment [Table Text Block]

The following tables show operating results for the Company’s reportable segments, along with reconciliation from segment gross profit (loss) from operations, the most directly comparable measure in accordance with generally accepted accounting principles in the United States, or GAAP:

 

    Three months ended June 30, 2012  
    Reference
Neurometric		     Clinic     Eliminations     Total  
Revenues   $ 38,000     $ 158,000     $ (5,200 )   $  190,800  
                                 
Operating expenses:                                
Cost of revenues     35,500       5,200       (5,200 )     35,500  
Research     66,300       -       -       66,300  
Product Development     200,900       -       -       200,900  
Sales and marketing     223,200       2,800       -       226,000  
General and administrative     660,300       256,400       -       916,700  
Total operating expenses     1,186,200       264,400       (5,200 )     1,445,400  
                                 
Loss from operations   $ (1,148,200 )   $ (106,400 )   $ -     $ (1,254,600 )

 

    Three months ended June 30, 2011  
    Reference
Neurometric		     Clinic     Eliminations     Total  
Revenues   $  33,200     $  172,800     $ (8,200 )   $  197,800  
                                 
Operating expenses:                                
Cost of revenues     37,800       8,200       (8,200 )     37,800  
Research     77,700       -       -       77,700  
Product Development     104,100       -       -       104,100  
Sales and marketing     333,200       33,400       -       366,600  
General and administrative     780,600       280,100       -       1,060,700  
Total operating expenses     1,333,400       321,700       (8,200 )     1,646,900  
                                 
Loss from operations   $ (1,300,200 )   $ (148,900 )   $ -     $ (1,449,100 )

  

    Nine months ended June 30, 2012  
    Reference
Neurometric		     Clinic     Eliminations     Total  
Revenues   $ 113,200     $ 499,100     $  (23,200 )   $  589,100  
                                 
Operating expenses:                                
Cost of revenues     110,700       23,200       (23,200 )     110,700  
Research     203,400       -       -       203,400  
Product Development     476,200       -       -       476,200  
Sales and marketing     813,600       57,500       -       871,100  
General and administrative     2,257,300       771,100       -       3,028,400  
Total operating expenses     3,861,200       851,800       (23,200 )     4,689,800  
                                 
Loss from operations   $ (3,748,000 )   $ (352,700 )   $ -     $ (4,100,700 )

 

    Nine months ended June 30, 2011  
    Reference
Neurometric		     Clinic     Eliminations     Total  
Revenues   $ 106,000     $ 456,000     $ (24,600 )   $ 537,400  
                                 
Operating expenses:                                
Cost of revenues     110,300       24,600       (24,600 )     110,300  
Research     408,100       -       -       408,100  
Product Development     364,800       -       -       364,800  
Sales and marketing     895,400       65,500       -       960,900  
General and administrative     2,381,100       812,700       -       3,193,800  
Total operating expenses     4,159,700       902,800       (24,600 )     5,037,900  
                                 
Loss from operations   $ (4,053,700 )   $ (446,800 )   $ -     $ (4,500,500 )
Schedule Of Segment Reporting Information, Total Assets, By Segment [Table Text Block]

The following table includes selected segment financial information as of June 30, 2012, related to total assets:

 

    Reference 
Neurometric		     Clinic     Total  
Total assets   $ 145,000     $ 40,300     $ 185,300